Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Genomic Characterization Of Histiocytic Lesions Following Pediatric T-Cell Acute Lymphoblastic Leukemia

Richard McMasters, MD, Brian K. Turpin, DO, Michael J. Absalon, MD, PhD, Christine L. Phillips, MD, Karen Burns, MD, Christopher E. Dandoy, MD, Nihal Bakeer, MBBS, Jun Mo, MD, John Perentesis, MD, Maureen M. O'Brien, MD

Blood (2013) 122 (21): 4940.

https://doi.org/10.1182/blood.V122.21.4940.4940

Published: 2013

Journal Articles

Prevalence and Clinical Characterization of CD20 and CD22 Expression in Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia

Melissa S Rayburg, MD, Daniel Marmer, Jun Mo, Richard McMasters, Teresa Smolarek, Beatrice Lampkin, John Perentesis

Blood (2008) 112 (11): 4872.

https://doi.org/10.1182/blood.V112.11.4872.4872

Published: 2008

Journal Articles

Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis

Linda Yang, Lei Wang, Theodosia A. Kalfa, Jose A. Cancelas, Xun Shang, Suvarnamala Pushkaran, Jun Mo, David A. Williams, Yi Zheng

Blood (2007) 110 (12): 3853–3861.

https://doi.org/10.1182/blood-2007-03-079582

Published: 2007

Journal Articles

Gene Targeting of Cdc42 Reveals Its Essential Role in T Cell Development and Homeostasis.

Fukun Guo, PhD, David Hildeman, Ph.D., Jun Mo, M.D., Yi Zheng, Ph.D.

Blood (2007) 110 (11): 794.

https://doi.org/10.1182/blood.V110.11.794.794

Published: 2007

Journal Articles

Tolerability of Chemotherapy for AML or MDS in Children with Fanconi Anemia.

Parinda A. Mehta, MD, Talia Ileri, MD, Richard E. Harris, MD, David A. Williams, MD, Arleen D. Auerbach, MD, Franklin O. Smith, MD, Jun Mo, MD, Teresa Smolarek, MD, Patrick Kelly, MD, Stella M. Davies, MD

Blood (2005) 106 (11): 898.

https://doi.org/10.1182/blood.V106.11.898.898

Published: 2005

Journal Articles

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

Yogen Saunthararajah, Ryotaro Nakamura, Jun-Mo Nam, Jamie Robyn, Fausto Loberiza, Jaroslaw P. Maciejewski, Toni Simonis, Jeffrey Molldrem, Neal S. Young, A. John Barrett

Blood (2002) 100 (5): 1570–1574.

https://doi.org/10.1182/blood.V100.5.1570.h81702001570_1570_1574

Published: 2002

NARROW

Genomic Characterization Of Histiocytic Lesions Following Pediatric T-Cell Acute Lymphoblastic Leukemia

Prevalence and Clinical Characterization of CD20 and CD22 Expression in Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia

Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis

Gene Targeting of Cdc42 Reveals Its Essential Role in T Cell Development and Homeostasis.

Tolerability of Chemotherapy for AML or MDS in Children with Fanconi Anemia.

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

Email alerts

ASH Publications

American Society of Hematology

Genomic Characterization Of Histiocytic Lesions Following Pediatric T-Cell Acute Lymphoblastic Leukemia

Prevalence and Clinical Characterization of CD20 and CD22 Expression in Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia

Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis

Gene Targeting of Cdc42 Reveals Its Essential Role in T Cell Development and Homeostasis.

Tolerability of Chemotherapy for AML or MDS in Children with Fanconi Anemia.

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only